ACLA 2017 Annual Meeting Photo Gallery

ACLA Comments on Bucshon-DeGette Discussion Draft Impacting the Regulation of Clinical Laboratory Diagnostics

ACLA Commends CMS’ Decision to Exercise Enforcement Discretion for Reporting Applicable Information Under PAMA

Clinical Laboratories, Laboratory Professionals, Physicians Urge HHS to Delay PAMA Implementation

Leaders in the Clinical Laboratory Community Address Issues Impacting Diagnostics at ACLA’s 22nd Annual Conference

Julie Khani to Lead ACLA as Next President

Retiring President Alan Mertz to Assume Role as Key Policy Advisor

READ MORE »

Key Lawmakers Support the FDA’s Decision to Delay Final Guidance on Laboratory-Developed Tests

The Protecting Access to Medicare Act of 2014

Big changes are coming to how Medicare pays for clinical lab services – here’s everything your lab needs to know about the new law. 

Learn More »

Join ACLA

Learn about the benefits of joining the nation’s leading advocacy organization for clinical laboratories.

JOIN US »

View all news & updates » Recent News & Updates

View all news & updates »

Policy Issues

  • Reimbursement and Coverage

    Medicare cuts to clinical labs threaten jobs, stifle innovation, and put patient access to vital lab tests at risk.

    Continue Reading »

  • Laboratory Developed Tests

    FDA regulation of laboratory-developed tests (LDTs) is duplicative, outside of FDA jurisdiction, and would negatively impact patient access to vital lab tests.

    Continue Reading »

  • IOAS Exception

    Self-referral leads to over-utilization, mistreated patients, and billions of wasted Medicare dollars. It’s time to close the loophole.

    Continue Reading »

View all policy issues »